デフォルト表紙
市場調査レポート
商品コード
1786454

DNAシンセサイザーの世界市場

DNA Synthesizer


出版日
ページ情報
英文 221 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
DNAシンセサイザーの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 221 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

DNAシンセサイザーの世界市場は2030年までに7億8,780万米ドルに達する見込み

2024年に3億2,250万米ドルと推定されるDNAシンセサイザーの世界市場は、2030年には7億8,780万米ドルに達し、分析期間2024-2030年のCAGRは16.1%で成長すると予測されます。本レポートで分析したセグメントの1つであるベンチトップDNA合成機は、CAGR17.9%を記録し、分析期間終了時には5億4,980万米ドルに達すると予測されます。大規模DNA合成装置セグメントの成長率は、分析期間中CAGR 12.5%と推定されます。

米国市場は8,480万米ドルと推定、中国はCAGR15.0%で成長予測

米国のDNAシンセサイザー市場は、2024年に8,480万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR15.0%で推移し、2030年には1億2,110万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ15.0%と13.7%と予測されています。欧州では、ドイツがCAGR 11.6%で成長すると予測されています。

世界のDNAシンセサイザー市場- 主要動向と促進要因のまとめ

合成DNAはバイオ技術革新の次の波を支える燃料か?

合成DNAに対する需要の高まりは、バイオテクノロジーのパラダイムシフトを促しており、DNA合成装置はこの変革の中心に位置しています。カスタムDNA配列の自動組立てを可能にするDNA合成機は、研究、診断、治療、産業バイオテクノロジーにとって不可欠なツールとなっています。合成生物学が勢いを増すにつれ、科学者たちは合成DNAを使って遺伝子回路を設計し、新しい生物を作り、ゲノム全体をゼロから構築しています。オリゴヌクレオチドや遺伝子断片を高い精度で迅速に生産する能力は、CRISPR遺伝子編集、mRNA治療薬、ワクチン開発、代謝工学などの研究を加速させています。例えばCOVID-19では、研究者がシンセサイザーを活用して抗原産生用のウイルス遺伝子を迅速に試作したことから、ワクチン開発における合成DNAの価値が強調されました。さらに、DNA合成のコストが下がり続けているため、より多くの研究機関やバイオテクノロジー新興企業が、外注費を削減し、プロジェクトの納期を向上させるために、ラボに合成機を組み込んでいます。学術機関、製薬会社、開発業務受託機関(CRO)は、より柔軟でハイスループットなワークフローを実現するために、社内合成能力への依存度を高めています。DNA合成機は現在、単一遺伝子合成から、ゲノムアセンブリ、遺伝子ライブラリー、DNAベースのデータ保存実験用の大規模DNA製造へのシフトを可能にしています。このようにライフサイエンスのほぼすべての領域で合成DNAの需要が高まっていることから、DNA合成装置は研究、イノベーション、バイオ製造の未来を牽引する戦略的技術として位置づけられています。

技術の進歩はDNA合成のスピード、精度、規模をどのように高めているのか?

DNAシンセサイザー技術は、スピード、精度、収率、スケーラビリティの向上を目指した技術革新により、近年著しく進歩しています。従来のホスホルアミダイトベースの固相合成は、長い間、短いオリゴヌクレオチドのゴールドスタンダードであったが、配列の長さとエラーの蓄積における限界に直面していました。これらの障壁を克服するために、酵素的DNA合成のような新しい技術が注目されています。これらの方法は、より長く正確なDNA鎖を、より穏やかな水性条件下で合成するために、操作されたポリメラーゼとテンプレートフリーの反応を使用します。さらに、マイクロアレイベースの合成プラットフォームは、現在、1チップ上で数千のDNA配列の並列生産を可能にし、コストを削減し、遺伝子ライブラリーやスクリーニングアッセイのような大規模なアプリケーションをサポートしています。ロボット工学やオートメーションとの統合により、DNA合成装置はより使いやすくなり、最小限の人的介入でウォークアウェイ合成が可能になりました。リアルタイムモニタリングシステムや、質量分析計やキャピラリー電気泳動などの高度な品質管理ツールは、製品の純度や収率を保証するために次世代合成機に組み込まれています。AIや機械学習アルゴリズムも、リアルタイムで合成エラーを予測し、プロトコルを最適化するために活用され、再現性とカスタマイズ性を高めています。これらの技術革新は、DNA合成の範囲を標準的な研究室での使用を超えて、臨床研究、精密医療、工業規模の生産にまで拡大しつつあります。合成的に操作できるもの限界を押し広げることによって、最新のDNA合成機は、ゲノム科学のペースと可能性を再構築する上で重要な役割を果たしています。

エンドユーザー層の拡大がDNAシンセサイザー市場の商業戦略を再構築?

DNAシンセサイザー市場は、エンドユーザー層の多様化が顕著であり、メーカー各社は、様々な専門知識レベル、アプリケーションフォーカス、スループットニーズに合わせて、技術やサービスをカスタマイズする必要に迫られています。学術機関や中核的な研究所は依然として主要ユーザーであり、遺伝子や細胞生物学の基礎研究にシンセサイザーを活用しています。しかし、臨床試験、治療法開拓、製品革新のために大量かつ用途に特化したDNA合成を必要とする製薬会社、診断薬会社、合成生物学の新興企業での採用が急増しています。農業、工業用酵素、バイオ燃料の分野で活躍する企業も、遺伝子組み換え作物(GMO)や微生物生産システムを最適化するためにDNA合成装置を使用しています。DNAデータ・ストレージへの関心の高まりは、デジタル・データをDNA鎖にエンコードするために調整された大容量シンセサイザーというニッチ分野を生み出しています。需要が多様化するにつれて、商業戦略も進化しています。メーカーは現在、低スループットのラボ向けのベンチトップ合成機、産業ユーザー向けの大容量プラットフォーム、物理的な装置を所有せずにアクセスしたい機関向けのクラウドベースの合成-as-a-サービスモデルを提供しています。これらのサービスモデルは、大規模な資本支出なしに高品質のDNAへのコスト効率の良いアクセスを求める新興企業や学術研究者に特に人気があります。さらに、トレーニングプログラム、ソフトウェア統合、オンデマンドサポートは、あらゆるレベルのユーザーが効果的にシンセサイザーを操作し、維持できるようにするために、商業的提供に不可欠なものとなりつつあります。テクノロジーを多様なユーザーグループのニーズに合わせることで、企業は市場での地位を強化し、ライフサイエンス分野全体にわたってDNA合成の社内導入の拡大を促進しています。

世界的にDNA合成装置の需要を促進している主な市場促進要因は何か?

DNAシンセサイザー市場の成長は、技術革新、アプリケーションの拡大、ユーザーニーズの進化に根ざしたいくつかの連動した要因によって牽引されています。主な要因の1つは、治療、農業、バイオ製造などの分野で合成生物学の採用が増加していることであり、そこでは合成DNAが生物システムやカスタム生物の設計の基礎となっています。特にmRNAやDNAベースのプラットフォームなど、ワクチン開発における迅速なプロトタイピングの必要性も、高スループットDNA合成装置への投資に拍車をかけています。さらに、CRISPRと遺伝子編集研究の世界の拡大が、精密に設計されたガイドRNAとドナーテンプレートの必要性を高めており、合成装置の使用率をさらに押し上げています。もう一つの成長要因は、アウトソーシングへの依存を減らし、プロジェクトのタイムラインを加速させる分散型の社内DNA合成ソリューションへの需要であり、特にペースの速いバイオテクノロジー環境では重要です。ラボのワークフローへの自動合成機の統合が進み、費用対効果の高い消耗品の開発と相まって、DNA合成は中規模ラボや新興企業にとってより身近なものとなっています。個別化医療や精密診断を支持する規制動向も、標的アッセイ開発や臨床研究用のDNAを生産できる合成機の開発を刺激しています。さらに、合成機メーカー、学術機関、製薬会社間の戦略的提携は、製品の革新と流通を加速させています。酵素やチップベースのシステムなどの次世代合成技術の登場は、持続可能性、精度、拡張性を向上させ、新たな商業的道を開いています。最後に、バイオテクノロジー教育と人材開拓への関心の高まりが、アカデミック合成機とトレーニングキットの需要を生み出し、長期的な市場拡大を確実なものにしています。このように、DNA合成機は、ゲノム科学と生物工学の次のフロンティアを支える基盤技術として位置づけられています。

セグメント

タイプ(ベンチトップDNA合成機、大型DNA合成機)、用途(創薬・研究開発用途、遺伝子工学用途、臨床診断用途)、最終用途(学術・研究機関最終用途、製薬・バイオ企業最終用途、臨床研究所最終用途)

調査対象企業の例

  • Agilent Technologies, Inc.
  • Applied Biosystems(Thermo Fisher Scientific)
  • ATDBio Ltd.
  • ATG:biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear B.V.
  • BioAutomation Corporation
  • Biolegio B.V.
  • Biosearch Technologies(LGC Group)
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.(IDT)
  • Kilobaser GmbH
  • LGC Biosearch Technologies

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30560

Global DNA Synthesizer Market to Reach US$787.8 Million by 2030

The global market for DNA Synthesizer estimated at US$322.5 Million in the year 2024, is expected to reach US$787.8 Million by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Benchtop DNA Synthesizers, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$549.8 Million by the end of the analysis period. Growth in the Large-scale DNA Synthesizers segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$84.8 Million While China is Forecast to Grow at 15.0% CAGR

The DNA Synthesizer market in the U.S. is estimated at US$84.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$121.1 Million by the year 2030 trailing a CAGR of 15.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 13.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.

Global DNA Synthesizer Market - Key Trends & Drivers Summarized

Is Synthetic DNA the Fuel Behind the Next Wave of Biotech Innovation?

The rising demand for synthetic DNA is driving a paradigm shift across the biotechnology landscape, with DNA synthesizers positioned at the heart of this transformation. DNA synthesizers, which enable the automated assembly of custom DNA sequences, have become indispensable tools for research, diagnostics, therapeutics, and industrial biotechnology. As synthetic biology gains momentum, scientists are using synthesized DNA to design gene circuits, create novel organisms, and build entire genomes from scratch. The ability to rapidly produce oligonucleotides and gene fragments with high accuracy is accelerating research in CRISPR gene editing, mRNA therapeutics, vaccine development, and metabolic engineering. COVID-19, for example, underscored the value of synthetic DNA in vaccine development, as researchers leveraged synthesizers to quickly prototype viral genes for antigen production. Furthermore, as the cost of DNA synthesis continues to decline, more institutions and biotech startups are integrating synthesizers into their labs to reduce outsourcing costs and enhance project turnaround times. Academic institutions, pharmaceutical companies, and contract research organizations (CROs) are increasingly relying on in-house synthesis capabilities for more flexible and high-throughput workflows. DNA synthesizers are now enabling a shift from single-gene synthesis to large-scale DNA manufacturing for genome assembly, gene libraries, and DNA-based data storage experiments. This growing demand for synthetic DNA in nearly every domain of life sciences positions DNA synthesizers as a strategic technology driving the future of research, innovation, and biomanufacturing.

How Are Technological Advancements Enhancing DNA Synthesis Speed, Accuracy, and Scale?

DNA synthesizer technologies have advanced significantly in recent years, with innovations aimed at improving speed, accuracy, yield, and scalability. Traditional phosphoramidite-based solid-phase synthesis has long been the gold standard for short oligonucleotides, but it faces limitations in sequence length and error accumulation. To overcome these barriers, emerging techniques such as enzymatic DNA synthesis are gaining attention. These methods use engineered polymerases and template-free reactions to synthesize longer and more accurate DNA strands under milder, aqueous conditions-offering potential breakthroughs in both sustainability and efficiency. Additionally, microarray-based synthesis platforms now allow parallel production of thousands of DNA sequences on a single chip, reducing costs and supporting large-scale applications like gene libraries and screening assays. Integration with robotics and automation has made DNA synthesizers more user-friendly, enabling walkaway synthesis with minimal human intervention. Real-time monitoring systems and advanced quality control tools-such as mass spectrometry and capillary electrophoresis-are being incorporated into next-generation synthesizers to ensure product purity and yield. AI and machine learning algorithms are also being utilized to predict synthesis errors and optimize protocols in real time, increasing reproducibility and customization. These innovations are expanding the reach of DNA synthesis beyond standard laboratory use to clinical research, precision medicine, and industrial-scale production. By pushing the boundaries of what can be synthetically engineered, modern DNA synthesizers are playing a crucial role in reshaping the pace and potential of genomic science.

Is the Broadening End-User Base Reshaping Commercial Strategies in the DNA Synthesizer Market?

The DNA synthesizer market is experiencing significant diversification in its end-user base, which is prompting manufacturers to tailor their technologies and services to suit varying levels of expertise, application focus, and throughput needs. Academic institutions and core research labs remain key users, utilizing synthesizers for fundamental genetic and cellular biology research. However, the market is witnessing a sharp rise in adoption among pharmaceutical companies, diagnostics firms, and synthetic biology startups that require high-volume, application-specific DNA synthesis for clinical trials, therapeutic development, and product innovation. Companies working in the fields of agriculture, industrial enzymes, and biofuels are also using DNA synthesizers to optimize genetically modified organisms (GMOs) and microbial production systems. The growing interest in DNA data storage is creating a niche segment of high-capacity synthesizers tailored for encoding digital data into DNA strands. As demand diversifies, commercial strategies are evolving: manufacturers now offer benchtop synthesizers for low-throughput labs, high-capacity platforms for industrial users, and cloud-based synthesis-as-a-service models for institutions seeking access without owning physical equipment. These service models are particularly popular among startups and academic researchers looking for cost-effective access to high-quality DNA without large capital expenditure. Additionally, training programs, software integrations, and on-demand support are becoming integral to commercial offerings, ensuring that users of all levels can effectively operate and maintain synthesizers. By aligning technology with the needs of diverse user groups, companies are strengthening their market position and fostering broader adoption of in-house DNA synthesis capabilities across the life sciences spectrum.

What Are the Key Market Drivers Fueling Demand for DNA Synthesizers Globally?

The growth in the DNA synthesizer market is driven by several interlinked factors rooted in technological innovation, expanding applications, and evolving user demands. One of the primary drivers is the rising adoption of synthetic biology in fields such as therapeutics, agriculture, and bio-manufacturing, where synthetic DNA is foundational to designing biological systems and custom organisms. The need for rapid prototyping in vaccine development, especially mRNA and DNA-based platforms, is also fueling investment in high-throughput DNA synthesis equipment. Additionally, the global expansion of CRISPR and gene editing research is driving the need for precision-engineered guide RNAs and donor templates, further boosting synthesizer usage. Another growth factor is the demand for decentralized, in-house DNA synthesis solutions that reduce dependency on outsourcing and accelerate project timelines-especially important in fast-paced biotech environments. The increasing integration of automated synthesizers into lab workflows, coupled with the development of cost-effective consumables, is making DNA synthesis more accessible to mid-sized labs and startups. Regulatory trends favoring personalized medicine and precision diagnostics are also stimulating the development of synthesizers that can produce DNA for targeted assay development and clinical research. Furthermore, strategic collaborations between synthesizer manufacturers, academic institutions, and pharmaceutical companies are accelerating product innovation and distribution. The advent of next-generation synthesis technologies, such as enzymatic and chip-based systems, is opening new commercial avenues with improved sustainability, accuracy, and scalability. Lastly, the growing focus on biotechnology education and workforce development is creating demand for academic synthesizers and training kits, ensuring long-term market expansion. Together, these diverse yet converging drivers are positioning DNA synthesizers as a cornerstone technology powering the next frontier of genomic science and bioengineering.

SCOPE OF STUDY:

The report analyzes the DNA Synthesizer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers); Application (Drug Discovery & Development Application, Genetic Engineering Application, Clinical Diagnostics Application); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, Clinical Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Applied Biosystems (Thermo Fisher Scientific)
  • ATDBio Ltd.
  • ATG:biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear B.V.
  • BioAutomation Corporation
  • Biolegio B.V.
  • Biosearch Technologies (LGC Group)
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc. (IDT)
  • Kilobaser GmbH
  • LGC Biosearch Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • DNA Synthesizer - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology and Genomic Engineering Throws the Spotlight on Automated DNA Synthesis Platforms
    • Rising Demand for Custom Genes and Oligonucleotides Propels Growth in On-Demand DNA Synthesizer Adoption
    • Declining Cost of DNA Synthesis Strengthens Business Case for In-House Synthesizer Integration
    • Advancements in Enzymatic and Chip-Based Synthesis Methods Accelerate Market Transition from Traditional Chemistries
    • Integration of DNA Synthesizers with Lab Automation Systems Drives Efficiency in High-Throughput Workflows
    • Proliferation of CRISPR and Gene Editing Applications Expands Use of Synthesizers in Research and Therapeutics
    • Growing Role of DNA in Data Storage and Nanotechnology Opens New Commercial Avenues for DNA Synthesizer Technologies
    • Academic and Biotech Startups Turn to Benchtop Synthesizers to Reduce Outsourcing and Speed R&D Cycles
    • Rising Demand for Synthetic Gene Libraries Spurs Need for Scalable, Multiplexed Synthesis Platforms
    • Use of AI for Sequence Optimization Enhances Accuracy, Customization, and Yield of Synthesized DNA
    • Growth in Vaccine Development and mRNA Therapeutics Generates Demand for Rapid and Flexible DNA Synthesis
    • Expansion of Biofoundries and Distributed Manufacturing Models Strengthens Demand for Modular Synthesizer Units
    • Global Investment in Synthetic Genomics Research Sustains Long-Term Growth Opportunities for DNA Synthesizer Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Synthesizer Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Large-scale DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION